Unlocking the Future of the Oncology Ablation Market: Growth Rate, Key Trends, and Opportunities for 2025-2034
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the oncology ablation market size evolved in recent years?
In recent years, the oncology ablation market has experienced significant expansion. Its worth is projected to increase from $1.3 billion in 2024 to $1.46 billion in 2025, showing a compound annual growth rate (CAGR) of 12.9%. Several factors have contributed to this growth during the historic period, including the rising incidence of cancer, an upsurge in the preference for less invasive ablation procedures, augmented healthcare expenses, the approval of new ablation tools and technologies, enhanced cancer screening initiatives, and an increase in the elderly population.
What are the predictions for the oncology ablation market size in the coming years?
The market size for oncology ablation is predicted to experience significant growth in the upcoming years, ultimately reaching a value of $2.35 billion in 2029 with a compound annual growth rate (CAGR) of 12.6%. This radical growth can be linked to the multiple advancements in the sphere of ablation technology, coupled with its increasing acceptance in progressing economies. Further factors contributing to the growth are inclinations towards personalised and precision medicine, heightened government aid and funding towards cancer research and treatments, and a growing demand for outpatient services. Better public and professional understanding also plays a role in the growth. The forecast period highlights several key trends including the use of artificial intelligence (AI) in the field, progression in imaging technologies, the employment of robotic-aided ablation, the emergence of advanced ablation tools designed for higher efficiency, safety, and user comfort, and the adoption of telemedicine for initial and follow-up ablation care, making remote monitoring feasible.
Get your oncology ablation market report here!
https://www.thebusinessresearchcompany.com/report/oncology-ablation-global-market-report
What key factors are fueling the growth of the oncology ablation market?
The growth of the oncology ablation market is expected to be driven by the rising number of cancer diagnoses. Cancer diagnosis involves the determination and confirmation of cancer presence via medical examinations, imaging, and pathological tissue sample analyses. The escalating number of cancer diagnoses can be attributed to a variety of reasons, including an aging population, more efficient screening programs, increased awareness leading to earlier detection, and environmental factors. Oncology ablation, a method used to treat tumors identified through cancer diagnoses, provides less invasive alternatives to eliminate tumors and enhance patient results. For example, the National Cancer Institute, the main agency of the U.S. federal government for cancer research and training, projected in May 2024 that there will be approximately 2,001,140 new cancer instances in the U.S. in 2024, with prostate, lung, and colorectal cancers accounting for about 48% of all diagnoses in males. By 2040, it’s predicted that the yearly number of novel cancer cases will rise to 29.9 million, indicating a substantial future rise in cancer rates. The American Cancer Society, a nonprofit organization in the U.S. that focuses on cancer awareness, reported in June 2022 that there were approximately 1.9 million new cancer cases diagnosed in the U.S. in 2022. As such, the oncology ablation market is anticipated to be propelled by the increased number of cancer diagnoses.
How is the global oncology ablation market divided into key segments?
The oncology ablation market covered in this report is segmented –
1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation
2) By Treatment: Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation
3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer
Subsegments:
1) By Radiofrequency Ablation: Monopolar Radiofrequency Ablation, Bipolar Radiofrequency Ablation
2) By Microwave Ablation: Single-Probe Microwave Ablation, Multi-Probe Microwave Ablation
3) By Cryoablation: Cryo-Needle Ablation, Cryo-Generator System Ablation
4) By Irreversible Electroporation Ablation: Transurethral IRE, Transperineal IRE, Percutaneous IRE
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18415&type=smp
Who are the key firms paving the way for growth in the oncology ablation market?
Major companies operating in the oncology ablation market are Medtronic plc, Siemens Healthineers AG, Becton Dickinson and Company, Koninklijke Philips N.V., Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Varian Medical Systems Inc, PENTAX Medical, Elekta AB, Merit Medical Systems Inc, AtriCure Inc, AngioDynamics Inc., EDAP TMS S.A., Monteris Medical Inc., Misonix Inc., MedWaves Inc., BSD Medical Corporation, Cardiva Medical Inc.
How are evolving market trends shaping oncology ablation Strategies?
Leading firms in the oncology ablation industry are pushing boundaries with innovative products such as advanced ablation systems featuring superior precision, integrated real-time imaging technology, and enhanced safety attributes. Precise advanced ablation systems refer to healthcare devices that utilize cutting-edge technology to specifically target and obliterate irregular tissue like tumors, whilst mitigating damage to neighboring healthy tissue. For example, Medtronic Plc, an Irish maker of medical equipment, obtained U.S. Food and Drug Administration approval in March 2024 for their OsteoCool 2.0 bone tumor ablation system. This system, designed to address painful bone metastases and benign tumors like osteoid osteoma, brings major improvements. These include the capacity to utilize four internally cooled probes concurrently, enabling the ablation of two vertebral bodies together, or developing larger ablation zones for non-spinal applications.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18415
What regions are contributing significantly to the growth of the oncology ablation market?
North America was the largest region in the oncology ablation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncology ablation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Interventional Oncology Devices Global Market Report 2024
Oncology Biosimilars Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/oncology-biosimilar-global-market-report
Oncology Molecular Diagnostics Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
